1 |
Gravholt CH. Epidemiological, endocrine and metabolic features in Turner syndrome. Eur J Endocrinol 2004;151:657-87
DOI
ScienceOn
|
2 |
Cicognani A, Mazzanti L, Tassinari D, Pellacani A, Forabosco A, Landi L, et al. Differences in carbohydrate tolerance in Turner syndrome depending on age and karyotype. Eur J Pediatr 1988;148:64-8
DOI
ScienceOn
|
3 |
Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9
DOI
ScienceOn
|
4 |
Gravholt CH, Naeraa RW, Nyholm B, Gerdes LU, Christiansen E, Schmitz O, et al. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care 1998;21:1062-70
DOI
ScienceOn
|
5 |
Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner syndrome. J Clin Epidemiol 1998;51:147-58
DOI
ScienceOn
|
6 |
Swerdlow AJ, Hermon C, Jacobs PA, Alberman E, Beral V, Daker M, et al. Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Ann Hum Genet 2001;65:177-88
DOI
ScienceOn
|
7 |
Cooley M, Bakalov V, Bondy CA. Lipid profiles in women with 45,X vs 46,XX primary ovarian failure. JAMA 2003; 290:2127-8
DOI
ScienceOn
|
8 |
Sybert VP, McCauley E. Turner's syndrome. N Engl J Med 2004;351:1227-38
DOI
PUBMED
ScienceOn
|
9 |
Lee S, Choi S, Kim HJ, Chung, YS, Lee KW, Lee HC, et al. Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci 2006;21:695-700
DOI
ScienceOn
|
10 |
Lebovitz HE. Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes 2001;109(2 Suppl):135S-48S
DOI
ScienceOn
|
11 |
Park JS, Park HD, Yun JW, Jung CH, Lee WY, Kim SW. Prevalence of the metabolic syndrome as defined by NCEP- ATPIII among the urban Korean population. Korean J Med 2002;63:290-9
|
12 |
Bondy CA. Care of girls and women with Turner syndrome: A guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 2007;92:10-25
|
13 |
Aligeti VR, Horn HR. Turner's syndrome and coronary artery disease. Am J Cardiol 2007;99:741-2
DOI
ScienceOn
|
14 |
Caprio S, Boulware S, Diamond M, Sherwin RS, Carpenter TO, Rubin K, et al. Insulin resistance: an early metabolic defect of Turner's syndrome. J Clin Endocrinol Metab 1991; 72:832-6
DOI
|
15 |
Elsheikh M, Conway GS. The impact of obesity on cardiovascular risk factors in Turner's syndrome. Clin Endocrinol (Oxf) 1998;49:447-50
DOI
ScienceOn
|
16 |
Nathwani NC, Unwin R, Brook CG, Hindmarsh PC. Blood pressure and Turner syndrome. Clin Endocrinol (Oxf) 2000; 52:363-70
DOI
ScienceOn
|
17 |
Facchini FS, Hua N, Abbasi F, Raven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 2001;86:3574-8
DOI
ScienceOn
|
18 |
Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16
DOI
ScienceOn
|
19 |
Finegood DT, Hramiak IM, DupreJ. A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 1990;70:1538-49
DOI
|
20 |
Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998;47:1643-9
DOI
ScienceOn
|
21 |
Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63
DOI
ScienceOn
|
22 |
Virdis R, Cantu MC, Ghizzoni L, Ammenti A, Nori G, Volta C, et al. Blood pressure behaviour and control in Turner syndrome. Clin Exp Hypertens A 1986;8:787-91
DOI
|
23 |
Yip J, Facchini FS, Reaven GM. Resistance to insulin- mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 1998;83:2773-6
DOI
ScienceOn
|
24 |
Ross JL, Feuillan P, Long LM, Kowal K, Kushner H, Cutler GB, Jr. Lipid abnormalities in Turner syndrome. J Pediatr 1995;126:242-5
DOI
ScienceOn
|
25 |
Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607
DOI
PUBMED
ScienceOn
|
26 |
Expert Panel on Detection, Evaluation Treatment of High Blood Cholesterol in, Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97
DOI
PUBMED
ScienceOn
|
27 |
Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003;26:3320-5
DOI
ScienceOn
|
28 |
Nielsen J, Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 1991;87:81-3
DOI
PUBMED
|
29 |
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9
DOI
ScienceOn
|
30 |
Bakalov VK, Cooley MM, Quon MJ, Luo ML, Yanovski JA, Nelson LM, et al. Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab 2004;89:3516- 20
DOI
ScienceOn
|